search icon

    Market Snapshot

    • S&P Futures

      3,819

    • Dow Futures

      30,822

    • Nasdaq Futures

      11,785

    blog search icon

    BioCardia, Inc.

    (NASDAQ:BCDA)

    $1.49

    $0.00

    -0.34%

    BioCardia, Inc. Chart

    BCDA Stock Price Today

    BioCardia, Inc. (BCDA) stock declined over -0.34% intraday to trade at $1.49 a share on NASDAQ. The stock opened with a loss of -3.87% at $1.54 and touched an intraday high of $1.54, falling -0.00% against the last close of $1.49. The stock went to a low of $1.45 during the session.

    Stock Snapshot

    $1.49

    Prev. Close

    25.74 Million

    Market Cap

    $1.45

    Day Low

    $1.54

    Open

    17.07 Million

    Number of Shares

    $1.54

    Day High

    -

    P/E ratio

    -0.76

    EPS (TTM)

    0.76

    Cash Flow per Share

    1.82

    Free Float in %

    0.80

    Book Value

    47,120

    Volume

    BioCardia, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-06$1.54$1.54$1.45$1.48547,120
    2022-07-05$1.55$1.55$1.45$1.4928,600
    2022-07-01$1.42$1.5$1.42$1.4637,400
    2022-06-30$1.39$1.52$1.39$1.4517,700
    2022-06-29$1.32$1.48$1.31$1.4452,500
    2022-06-28$1.45$1.53$1.4$1.4378,000
    2022-06-27$1.4$1.5$1.37$1.4517,200
    2022-06-24$1.5$1.54$1.34$1.4251,900
    2022-06-23$1.55$1.55$1.46$1.4723,800
    2022-06-22$1.42$1.5$1.32$1.573,700

    Contact Details

    320 Soquel Way
    Sunnyvale, CA 94085
    United States

    Webiste:BCDA

    650 226 0120

    Company Information

    Employees-

    Beta1.44

    Sales or Revenue1.01 Million

    5Y Sales Change12.00%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmonary disease. The company is also developing ALLOGENEIC Cell Therapy System, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system, a percutaneous catheter delivery system for cardiovascular regenerative medicine; and Morph deflectable guides and sheaths. The company is based in San Carlos, California.

    Frequently Asked Questions

    icon

    What is the current BioCardia, Inc. (BCDA) stock price?

    BioCardia, Inc. (NASDAQ: BCDA) stock price is $1.49 as of the last check on Wednesday, July 6. During the trading session, BCDA stock reached the peak price of $1.54 while $1.45 was the lowest point it dropped to.

    icon

    BCDA's industry and sector of operation?

    The NASDAQ listed BCDA is part of Biotechnology industry that operates in the broader Health Care sector. BioCardia, Inc. , a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases.

    icon

    Who are the executives of BCDA?

    Dr. Peter A. Altman Ph.D.
    CEO, Pres & Director
    Mr. David McClung
    Chief Financial Officer
    Mr. Edward M. Gillis
    Sr. VP of Devices
    Dr. Ian McNiece Ph.D.
    Chief Scientific Officer

    icon

    What is the BCDA stock price today?

    BCDA stock traded closed the last session at $1.485, which is $0.00 or -0.34% lower than its previous close of $1.49. BCDA's current trading price is 34.99% lower than its 52-week high of $3.96 where as its distance from 52-week low of 1.10% is -62.50%.

    icon

    How many employees does BCDA have?

    Number of BCDA employees currently stands at -. BCDA operates from 320 Soquel Way, Sunnyvale, CA 94085, United States.

    icon

    Link for BCDA official website?

    Official Webiste of $BCDA is: https://www.biocardia.com

    icon

    How do I contact BCDA?

    BCDA could be contacted at BCDA operates from 320 Soquel Way, Sunnyvale, CA 94085, United States, or at phone #650 226 0120 and can also be accessed through its website.

    icon

    How many shares of BCDA are traded daily?

    BCDA stock volume for the day was 47,120 shares while in the previous session number of BCDA shares traded was 47,120 . The average number of BCDA shares traded daily for last 3 months was 706.56 Thousands.

    icon

    How much did BCDA change today?

    The percentage change in BCDA stock occurred in the recent session was -0.34% while the dollar amount for the price change in BCDA stock was $0.00.

    icon

    What price range BCDA stock been trading in?

    In the recent session, the day high for BCDA stock was $1.54 while the low for BCDA stock touched on the day was $1.45.

    icon

    What is the market cap of BCDA currently?

    The market value of BCDA currently stands at 25.74 Million with its latest stock price at $1.49 and 17.07 Million of its shares outstanding.